Cargando…

Reasons for using cannabidiol: a cross-sectional study of French cannabidiol users

BACKGROUND: Cannabidiol and cannabidiol-based products are proliferating in many countries. This recent and rapid diffusion prompts investigating the reasons for its use. METHODS: We analyzed data from an online survey among cannabidiol users in the French general population (n = 1166) selected for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fortin, Davide, Di Beo, Vincent, Massin, Sophie, Bisiou, Yann, Carrieri, Patrizia, Barré, Tangui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Brief Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495963/ https://www.ncbi.nlm.nih.gov/pubmed/34615556 http://dx.doi.org/10.1186/s42238-021-00102-z

Ejemplares similares

A “Good” Smoke? The Off-Label Use of Cannabidiol to Reduce Cannabis Use
por: Fortin, Davide, et al.
Publicado: (2022)

Cannabidiol use and perceptions in France: a national survey
por: Casanova, Clémence, et al.
Publicado: (2022)

Adherence to opioid agonist therapy predicts uptake of direct-acting antivirals in people who use drugs: results from the French national healthcare database (the ANRS FANTASIO study)
por: Rolland, Benjamin, et al.
Publicado: (2022)

A Cross-Sectional Study of Cannabidiol Users
por: Corroon, Jamie, et al.
Publicado: (2018)

Medical Cannabis: Toward a New Policy and Health Model for an Ancient Medicine
por: Fortin, Davide, et al.
Publicado: (2022)

Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems
por: Moltke, Julie, et al.
Publicado: (2021)

Prolonged Cannabidiol Treatment Effects on Hippocampal Subfield Volumes in Current Cannabis Users
por: Beale, Camilla, et al.
Publicado: (2018)

Cannabidiol and Beta-Caryophyllene in Combination: A Therapeutic Functional Interaction
por: Blanton, Henry, et al.
Publicado: (2022)

Cannabidiol and Cannabidiol Metabolites: Pharmacokinetics, Interaction with Food, and Influence on Liver Function
por: Abbotts, Kieran Shay Struebin, et al.
Publicado: (2022)

Assessing the treatment of cannabidiolic acid methyl ester: a stable synthetic analogue of cannabidiolic acid on c-Fos and NeuN expression in the hypothalamus of rats
por: Murillo-Rodríguez, Eric, et al.
Publicado: (2021)

Cannabidiol in Parkinson’s disease
por: Rieder, Carlos R.
Publicado: (2020)

The antimicrobial potential of cannabidiol
por: Blaskovich, Mark A. T., et al.
Publicado: (2021)

Cannabidiol in the Treatment of Epilepsy
por: von Wrede, Randi, et al.
Publicado: (2021)

The Polypharmacological Effects of Cannabidiol
por: Castillo-Arellano, Jorge, et al.
Publicado: (2023)

Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?
por: Lachenmeier, Dirk W., et al.
Publicado: (2023)

Effects of Cannabidiol on Locomotor Activity
por: Calapai, Fabrizio, et al.
Publicado: (2022)

Plasma Pharmacokinetics of Cannabidiol Following Oral Administration of Cannabidiol Oil to Dairy Calves
por: Meyer, Kelsey, et al.
Publicado: (2022)

Towards Better Delivery of Cannabidiol (CBD)
por: Millar, Sophie Anne, et al.
Publicado: (2020)

Cannabidiol for Treatment of Childhood Epilepsy–A Cross-Sectional Survey
por: Klotz, Kerstin A., et al.
Publicado: (2018)

Effects of cannabidiol on weight and fasting blood sugar with chronic and subchronic haloperidol administration
por: Kajero, Jaiyeola Abiola, et al.
Publicado: (2022)

Cannabidiol Content and In Vitro Biological Activities of Commercial Cannabidiol Oils and Hemp Seed Oils
por: Kitamura, Masashi, et al.
Publicado: (2020)

Isolation, Purification, and Antimicrobial Characterization of Cannabidiolic Acid and Cannabidiol from Cannabis sativa L.
por: Martinenghi, Laura Daniela, et al.
Publicado: (2020)

Cannabidiol but not cannabidiolic acid reduces behavioural sensitisation to methamphetamine in rats, at pharmacologically effective doses
por: Umpierrez, Laísa S., et al.
Publicado: (2022)

Cannabidiol: potential in treatment of neurological diseases, flax as a possible natural source of cannabidiol
por: Storozhuk, Maksim V.
Publicado: (2023)

Therapeutic Prospects of Cannabidiol for Alcohol Use Disorder and Alcohol-Related Damages on the Liver and the Brain
por: De Ternay, Julia, et al.
Publicado: (2019)

Cannabidiol as a treatment for epilepsy
por: Pickrell, William O., et al.
Publicado: (2017)

Cannabidiol in epilepsy: The indications and beyond
por: Ryan, Melody
Publicado: (2020)

Immune Responses Regulated by Cannabidiol
por: Nichols, James M., et al.
Publicado: (2020)

Unexpected improvement of hyperhidrosis with cannabidiol
por: Pitliuk, Rubens, et al.
Publicado: (2022)

Cannabidiol (CBD) in Cancer Management
por: O’Brien, Kylie
Publicado: (2022)

Cannabidiol and Neurodevelopmental Disorders in Children
por: Kwan Cheung, Keith A., et al.
Publicado: (2021)

The Effects of Food on Cannabidiol Bioaccessibility
por: Mozaffari, Khadijeh, et al.
Publicado: (2021)

Suicidality and Cannabidiol: Opportunities and Challenges
por: Moazen-Zadeh, Ehsan, et al.
Publicado: (2021)

Hemp in Animal Diets—Cannabidiol
por: Fallahi, Sepideh, et al.
Publicado: (2022)

Acceptability of cannabidiol in patients with psychosis
por: Chesney, Edward, et al.
Publicado: (2022)

Pharmacovigilance on cannabidiol as an antiepileptic agent
por: Ammendolia, Ilaria, et al.
Publicado: (2023)

The therapeutic potential of purified cannabidiol
por: O’Sullivan, Saoirse Elizabeth, et al.
Publicado: (2023)

Cannabidiol Treatment for Refractory Epilepsies in Pediatrics
por: Raucci, Umberto, et al.
Publicado: (2020)

Cannabidiol as the Substrate in Acid-Catalyzed Intramolecular Cyclization
por: Marzullo, Paola, et al.
Publicado: (2020)

A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
por: Millar, Sophie A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3m6rb0aoabh4h5ml29osv36ifd